Wells Fargo
AGL icon

Wells Fargo’s Agilon Health AGL Stock Holding History

Wells Fargo’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
14,872
+10,344
+228% +$677K ﹤0.01% 3776
2026
Q1 		$35.8K Sell
4,528
-8,977
-66% -$145K ﹤0.01% 5563
2025
Q4 		$233K Buy
13,505
+5,917
+78% +$115K ﹤0.01% 4979
2025
Q3 		$195K Buy
7,588
+1,207
+19% +$45.6K ﹤0.01% 4943
2025
Q2 		$367K Buy
6,381
+473
+8% +$37.9K ﹤0.01% 4369
2025
Q1 		$640K Buy
5,908
+117
+2% +$10.2K ﹤0.01% 3918
2024
Q4 		$275K Buy
5,791
+1,866
+48% +$113K ﹤0.01% 4590
2024
Q3 		$386K Sell
3,925
-1,810
-32% -$234K ﹤0.01% 4162
2024
Q2 		$938K Buy
5,735
+4,084
+247% +$582K ﹤0.01% 3536
2024
Q1 		$252K Sell
1,651
-1,866
-53% -$310K ﹤0.01% 4322
2023
Q4 		$1.1M Buy
3,517
+769
+28% +$278K ﹤0.01% 3379
2023
Q3 		$1.22M Sell
2,748
-206
-7% -$93.1K ﹤0.01% 3188
2023
Q2 		$1.28M Buy
2,954
+821
+38% +$461K ﹤0.01% 3276
2023
Q1 		$1.27M Buy
2,133
+358
+20% +$201K ﹤0.01% 3213
2022
Q4 		$716K Sell
1,775
-365
-17% -$171K ﹤0.01% 3431
2022
Q3 		$1.25M Buy
2,140
+1,252
+141% +$750K ﹤0.01% 3078
2022
Q2 		$484K Buy
888
+3
+0.3% +$1.52K ﹤0.01% 3762
2022
Q1 		$560K Buy
885
+400
+82% +$206K ﹤0.01% 4327
2021
Q4 		$327K Buy
485
+393
+427% +$239K ﹤0.01% 4991
2021
Q3 		$61K Buy
92
+85
+1,214% +$72.6K ﹤0.01% 5547
2021
Q2 		$7K Buy
+7
New +$6.13K ﹤0.01% 6225

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Wells Fargo's AGL Position: Q2 2026 in Review

Wells Fargo increased its Agilon Health (AGL) stake by 228% in Q2 2026, buying an estimated $677K and bringing the position to 14,872 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #3776.

Wells Fargo first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Wells Fargo held 14,872 shares of Agilon Health worth $1.59M as of Q2 2026.
  • Wells Fargo bought 10,344 Agilon Health shares in Q2 2026, an estimated $677K.
  • Agilon Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3776 holding.
  • Wells Fargo first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.